Breast and lung cancer patients with low levels of TTP protein have poorer prognosis
Moffitt Cancer Center researchers have found that breast and lung cancer patients who have low levels of a protein called tristetraprolin (TTP) have more aggressive tumors and a poorer prognosis than those with high levels of the protein.
Linear Mode
